Shahrzad Zonoozi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Sitagliptin, a modern antidiabetic agent which is weight neutral and associated with low rate of hypoglycaemias, is being increasingly used in type 2 diabetes mellitus (DM). However, there is a paucity of data about its efficacy and safety in beta-thalassaemia major (β-TM). This retrospective case series of five patients (mean age of 45 years) is the first(More)
  • 1